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The advancements in medicine and medical technology have greatly improved the lives
o f millions of people in both developed and developing countries. With this
improvement in health has come an increase in life expectancy and subsequently an
increase in chronic diseases such as rheumatoid arthritis. Several studies conducted
worldwide have shown that rheumatoid arthritis has a higher average prevalence in all
three ancestral groups (Caucasoid, Mongoloid, Negroid) in countries in North America
when compared to ancestral groups living in other countries.
To attempt to explain this disparity, four economic and demographic variables thought
to be indicative of the health o f the population were applied to the prevalence of
rheumatoid arthritis for each country included in the present study. The four variables
consisted of gross domestic product-per capita, life expectancy o f the total population,
percentage of the population 65 years and older, and percentage of the population below
the poverty line. Unfortunately none of the variables were found to be significant when
using the Pearson Correlation and Linear Regression tests. Although, they were all found
to have significant relationships when compared with each other, with the exclusion o f
the prevalence of rheumatoid arthritis.
Other factors were also explored in an effort to account for the difference in prevalence
of rheumatoid arthritis between North American and non-North American ancestral
groups, which included accessibility of health care, cultural values, problems with
communication, attitudes and expectations towards modem medicine, and antiquity and
etiology o f rheumatoid arthritis. O f these, only cultural values and problems with
communications were found to have any impact on the outcome of the prevalence
studies.
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CHAPTER I
INTRODUCTION
With the rise in life expectancy throughout the world and the advancements that
have been made in modem medicine and medical technology, attention has been diverted
from infectious diseases (communicable) to chronic diseases (non-communicable). No
longer are chronic diseases affecting only individuals in developed countries. Their
impact and burden is widespread and felt in many developing countries as well. The
present study focuses on the group o f chronic diseases known as musculoskeletal
conditions, and more specifically on rheumatoid arthritis.
“Although the diseases that kill attract much of the public’s attention,
musculoskeletal conditions are the major cause o f morbidity throughout the world,
having a substantial influence on health and quality o f life, and inflicting an enormous
burden o f cost on health systems” (World Health Organization 2003:1). Their
importance is undervalued most likely because they are rarely fatal, are considered
irreversible, and are usually associated with advanced age. According to the World
Health Organization, “rheumatic diseases cause more pain and disability than any other
group of conditions in developed countries, and the same pattern o f morbidity is now
being seen in the developing world” (WHO 2003:2). In the United States in 1997, “an
estimated 16% of the population, or 43 million people, had some form o f arthritis”
(Reginster 2002:3) and as the age o f the population increases so will the impact of
arthritis on society. Rheumatoid arthritis affects between 2.1 and 2.5 million people in
the United States (National Institute o f Arthritis and Musculoskeletal and Skin Diseases,
National Institutes o f Health, American Medical Women’s Association). Rheumatoid
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arthritis has been shown to restrict “work capacity in a third o f people within the first
year” (Woolf and Akesson 2001:1080), with an average number of workdays lost
between 2,7 and 30 annually (Reginster 2002:5). Within a decade of onset, rheumatoid
arthritis may lead to a total cessation of employment in at least 51 percent of patients, and
perhaps as many as 59 percent (WHO 2003). This decrease in work capacity is
represented in the indirect costs of arthritis estimated at $47.8 billion by adding up the
amount of pay lost due to absence from work. This is only part of the economic burden
of arthritis, which is estimated to be $82.4 billion in the United States alone. The other
$34.6 billion is spent on medical expenditures o f the patient and health insurance
companies, part o f the direct costs o f arthritis. These numbers are represented in the total
economic burden o f a disease, which consists of direct costs, such as the costs associated
with medications, physician visits, hospital stays, and surgical procedures, indirect costs,
such as loss o f work productivity and chronic and short-term disability, andintangible
costs, such as increased pain and reduced quality o f life (Reginster 2002; Lubeck 2001).
Research and Goals
The goal of the present study is to locate a pattern among rheumatoid arthritis
prevalence rates in three ancestral populations (Caucasoid, Negroid, Mongoloid)
dependent upon their geographic location (North America, non-North America).
Assessing geographic and racial/ethnic variation in disease occurrence is one way to find
clues to the cause(s) o f disease. This is important because rheumatoid arthritis has an
unknown etiology or cause, and is becoming more and more of a burden to society. In
addition to racial and ethnic differences, economic, demographic, socioeconomic and
cultural factors will be considered in an attempt to explain the similarities and differences

in the prevalence of rheumatoid arthritis found between geographic regions. Racial and
ethnic differences in health status are often linked to these factors in ways that are not
always straightforward and are difficult to separate (Jordan 1999). This will be examined
to determine ways in which the results of the prevalence studies included here may have
been affected by this complexity.
Involvement
Musculoskeletal conditions affect hundreds o f millions of people around the
world and comprise about 150 diseases and syndromes. According to the World Health
Organization, the conditions that have “the greatest impact on society include rheumatoid
arthritis, osteoarthritis, osteoporosis, low back pain, and limb trauma” (WHO 2003).
“Musculoskeletal impairments ranked number one in chronic impairments in the United
States” (Woolf and Akesson 2001:1079) and on average they consume about three
percent o f total gross domestic product (GDP) in developed countries (WHO 2003). The
economic impact these conditions have on society is also expected to rise in developed
countries due to an ever increasing life expectancy and “to the predicted doubling o f the
number o f people over 50 by the year 2020” (www.usbjd.org 2004). It is evident that
some action needs to be taken to reduce this large burden.
Several organizations have gotten involved with this global dilemma and were
created to help find answers to the questions scientists are asking about many
musculoskeletal conditions. One o f the largest initiatives recently created, in partnership
with the World Health Organization, is the Bone and Joint Decade. “The Bone and Joint
Decade is a global, multi-disciplinary initiative targeting the care o f people with
musculoskeletal conditions—bone and joint disorders. Its focus is on improving your

quality of life as well as advancing the understanding and treatment of those conditions
through research, prevention and education” (www.usbjd.org 2004). The goals for the
United States, initiated in part by the estimated $254 billion annual cost of
musculoskeletal conditions in the United States, include (www.usbjd.org 2004):
•
•
•
•

Raise awareness about the growing burden o f musculoskeletal conditions
Promote prevention and empowerment through educational programs
Advance research in prevention, diagnosis and treatment
Improve diagnosis and treatment

In 1981, the World Health Organization-International League of Associations for
Rheumatology (WHO-ILAR) launched the Community Oriented Program for Control of
Rheumatic Diseases (COPCORD). The primary objective of this program was to acquire
data on the prevalence o f rheumatic-musculoskeletal symptoms and disorders (RMS) in
developing countries that have been neglected. Unfortunately many of the studies done
by the WHO-ILAR did not meet all o f the criteria established for the present study (see
Chapter II) and subsequently could not be included.
The World Health Organization along with many research organizations on a
smaller demographic scale such as the National Institute of Arthritis and Musculoskeletal
and Skin Diseases, Arthritis and Rheumatism International, the Arthritis Foundation, and
the American Rheumatism Association conduct research to help improve the lives of
millions of people through prevention and treatment o f arthritis and other
musculoskeletal diseases.
Two other organizations that are of interest include the National Databank for
Rheumatic Diseases (NDB) and the American Rheumatism Association Medical
Information System (ARAMIS). Both organizations act as a longitudinal research
databank for both rheumatology patients and physicians for rheumatoid arthritis.

osteoarthritis, fibromyalgia and other rheumatic diseases. Both are designed to improve
treatment and outcome for patients afflicted with rheumatic diseases. But unlike the
other organizations mentioned above, much o f the data is collected from rheumatologists
and their patients over many years (www.arthritis-research.org 2004; Fries and McShane
1986). While the mission o f these organizations is o f great significance, they may only
prove beneficial to those who are able to reap the benefits. Factors such as culture, social
status, wealth and education may limit many and prove far more important than any new
treatment or technological innovation.
Background
Rheumatoid arthritis is a worldwide disease. Unfortunately the disease is not very
well understood by the general public and is often confused with osteoarthritis. In order
to fully comprehend the present study, it is necessary to have at least a general
understanding of the disease process, how it may develop and whom it affects. This is
discussed briefly and separated into sections examining the clinical features and
diagnosis, pathology, etiology, classification, and antiquity of rheumatoid arthritis.
Clinical Features and Diagnosis of Rheumatoid Arthritis
Since the ‘natural history’ of rheumatoid arthritis is not completely understood,
largely because o f the unknown etiology, it is often difficult if not impossible for a
physician to predict the outcome and course of the disease for any patient. However, the
onset of rheumatoid arthritis can be more easily described with most patients having
either a gradual onset with development of symptoms over a period of several weeks,
abrupt and acute onset taking place over several days, or an isolated initial presentation.

It is difficult to determine what path or pattern the disease will take, but there are some
factors that give clues to the prognosis. Factors that are in a patient’s favor and may
predict a positive outcome include an acute onset o f the disease, periods of remission
within the first year, and being of the male sex. At first thought, it seems contradictory
that abrupt and severe attacks o f rheumatoid arthritis could have a favorable prognosis for
a patient but these patients usually seek medical advice from a rheumatologist much
sooner than a patient with a slow gradual onset who may delay seeking treatment. A
poor prognosis is associated with a gradual onset o f the disease with large joint
involvement, persistence for more than one year without remission, early appearance o f
bone erosions and rheumatoid nodules, and a positive rheumatoid factor (Lawrence and
Shulman 1984; Hochberg et al. 2003).
In the early stages o f rheumatoid arthritis many patients develop systemic
symptoms such as fatigue, malaise and weight loss, while a select few develop “acute
systemic toxicity with high fever, weakness and anemia” (Salter 1983:194). The disease
mainly involves the joints, primarily those of the hands (metacarpophalangeal and
proximal interphalangeal joints) and feet (metatarsophalangeal joints), and occasionally
the larger joints such as the hips, knees, and shoulders as well as the elbows, ankles and
vertebrae. This is characterized by pain and stiffness and most of all inflammation,
which includes redness, swelling, heat, and loss of function. As the disease progresses
these symptoms become more marked and are accompanied by muscle atrophy and
tendon and ligament involvement, which leads to a rapid development o f deformities in
the joints involved (Salter 1983:194).

As mentioned earlier, rheumatoid arthritis is a systemic disease. Though it is
generally thought to be a disease of the joints exclusively, it can affect many areas of the
body. Many patients will undergo extraarticular manifestations such as malaise and
fatigue but a small number will also experience inflammation in other organ systems as
well. Some o f these other systems include skin, ocular, respiratory, cardiac,
gastrointestinal, renal, neurologic, and hematological manifestations. Risk factors that
appear to influence the expression of these other manifestations include a positive
rheumatoid factor, presence of rheumatoid nodules, and severity o f the articular process
(Schumacher et al. 1993:93).
Pathology of Rheumatoid Arthritis
The pathology o f rheumatoid arthritis can be broken down into three stages
(Lawrence and Shulman 1984). The first stage begins with the initiation of synovitis in
the joints by the primary etiologic factor, which is still unknown. The synovium,
normally a thin membrane, reacts to the inflammation by becoming edematous and
protrudes into the joint cavity with villous projections. The next stage involves the
immunologic events that occur because o f the synovitis and perpetuate the initial
inflammatory reaction. “The resultant immune process within the diseased synovium
produces immune complexes which, in turn, activate a multitude o f chemical mediators
of inflammation” (Salter 1983:193). During this process hydrolytic enzymes are released
that begin to destroy the proteoglycans and collagen o f the cartilage matrix. The last
stage is when the inflammatory reaction in the synovium is modified into a destructive
granulation tissue called pannus. At this stage the joint ligaments and tendons may
become softened and stretched which can lead to muscle atrophy, subluxation o f the joint

and even dislocation. Subchondral bone becomes eroded at the margins of the joint
producing areas o f osteolysis and osteoporosis in the remaining bone. If this process
continues long enough, fibrous adhesions may form that can eventually ossify leading to
bony ankylosis.
Etiology of Rheumatoid Arthritis
A majority o f the literature on rheumatoid arthritis focuses on the causal factors or
etiology of the disease. As o f yet the etiology is still unknown, although there are a host
of factors that could be responsible. This is an important issue because in order to
successfully treat the symptoms and put the inflammatory reaction into remission, an
understanding of what is causing the disease must be known. These causal factors can be
broken down into five broad categories: genetic, environmental, hormonal, immunologic
and other.
Genetic Factors
Genetic studies have gained interest with scientists due to the observation of an
increased risk o f rheumatoid arthritis among relatives of those afflicted with the disease.
For some patients, rheumatoid arthritis is sporadic while others can identify a family
history. “Twin studies indicate that genetic factors may account for up to 60% of disease
susceptibility in RA” (Oilier et al. 2001:29). These results are in regards to monozygotic
(identical) twins, for dizygotic (firatemal) twins the percentage is less. This difference
may be due to the fact that monozygotic twins share the same environment in the womb
as well as similar conditions while maturing. Two studies done by Silman and Sanders
on sibling pairs found that there is no greater similarity either in age o f onset or calendar
year o f onset among siblings. This indicates that neither genetic nor environmental
8

factors were more important in explaining the development o f rheumatoid arthritis and
supports the idea that it occurs by chance (Silman and Hochbery 1993).
A relationship between human leukocyte antigen (HLA)-DR and rheumatoid
arthritis has been known for over 25 years. Several studies conducted with many
populations have revealed that a number of HLA-DRBl alleles are associated with
rheumatoid arthritis (Oilier et al, 2001). Unfortunately the only association that has been
found is that it is more of a marker for indicating severity and chronicity rather than
susceptibility. To date, no genes have been identified that code specifically for
rheumatoid arthritis susceptibility as it is likely that it is a complex disease that may
include multiple genetic and other factors.
Environmental Factors
Two groups of infectious agents, bacteria and viruses, have attracted the most
attention where environmental causes o f rheumatoid arthritis are concerned. To date “no
organisms have been consistently recovered from synovial tissue or fluid” (Oilier et al.
2001:32) from patients with recent onset rheumatoid arthritis. One reason bacteria and
viruses may be likely causes is because they can enter the blood stream and become
lodged in the joint or articular cavity causing inflammation and an immune response to
attack the foreign body. This immune reaction may perpetuate inflammation long after
the infectious agent has disappeared in those with a predisposition for rheumatoid
arthritis. No clear evidence o f rheumatoid arthritis clustering in space or time has been
found, but that does not negate the possibility that an infectious agent may trigger
rheumatoid arthritis in some individuals (Oilier et al. 2001).

Numerous pathogens have been investigated including the Epstein-Barr virus,
which has been extensively researched over several decades because of its effects on the
immune system. Serologic evidence has shown that more than 80 percent of adults have
had a previous infection and that the virus persists in the saliva and nasopharynx of about
20 percent of individuals (Lawrence and Shulman 1984). Those with rheumatoid arthritis
have been found to have a greater frequency of antibodies to the Epstein-Barr virus in
their blood. “Even though they may not have had a greater exposure to the EBV than
others, rheumatoid patients may be unable to contain the organism, thereby allowing it to
persist and produce disease” (Lawrence and Shulman 1984:116). Other infectious agents
such as human parvovirus have gained attention as well as “numerous other
microorganisms, not only viruses and bacteria but also protozoa with no overall
conclusion” (Silman and Hochberg 1993:47).
Hormonal Factors
Results from several studies conducted all over the world on many different
populations all have in common a female preponderance of rheumatoid arthritis. Clearly
there is some hormonal risk factor at work here. Some have suggested that rheumatoid
arthritis is associated with a low testosterone level in men and women, which would
explain why the female to male ratio tends to even out with advanced age (Oilier et al.
2001). Therefore male hormones may be protective against rheumatoid arthritis. A
problem with this conclusion is that rheumatoid arthritis may suppress testosterone, so it
is difficult to say whether it is a cause or an effect (Silman and Hochberg 1993).
Pregnancy has been shown to have protective effects against developing
rheumatoid arthritis and many who already have the disease go into remission during
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pregnancy. The postpartum period on the other hand is a time of increased susceptibility.
The oral contraceptive pill has been shown in several studies not to reduce the risk of
developing rheumatoid arthritis, but to modify the disease process into a milder form and
delay the onset for many years (Spector 1990). This theory is reinforced by the fact that
the age of onset o f rheumatoid arthritis in women is becoming higher while it remains
stable in men (Oilier et al. 2001). Estrogen replacement therapy has also been
investigated, although not nearly as extensively as the oral contraceptive pill. To date, no
conclusions have been made whether the therapy has any effect on the development or
management of rheumatoid arthritis.
Immunologic Factors
The features o f rheumatoid arthritis are suggestive o f an abnormal immune
system or one that is hypersensitive and persistent. About 70 percent of patients with
rheumatoid arthritis test positive for rheumatoid factor by serological means. For some,
they initially test negative for rheumatoid factor but develop it as the disease progresses.
Claiming that a positive rheumatoid factor is a marker for developing rheumatoid arthritis
is rather premature since it may also “occur in a variety of unrelated connective tissue
diseases” (Salter 1983:192) as well as in about three percent of healthy individuals that
never develop rheumatoid arthritis (Schumacher, 1993:87). From studies done on
animals, elevated levels o f rheumatoid factor are generated in times of chronic infection
to enhance the killing of microorganisms but may also cause inflammatory cell activation
and alter the immune complexes. “The available data suggest that rheumatoid factors
may play a role in amplifying rheumatoid inflammation but that they are not a primary
triggering or etiologic factor” (Schumacher et al. 1993:87).
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Other Factors
Some other factors that have been explored that may predispose an individual to
develop rheumatoid arthritis include psychological stress, trauma, diet, smoking, alcohol
consumption, obesity, infection, and immunization. Some have claimed that a
psychologically stressed, anxious, or depressed person is more prone to develop
rheumatoid arthritis. In reality these personality traits are more likely a result o f having
the disease (Salter 1983). Physical trauma has also been linked to rheumatoid arthritis,
but these studies have problems with interpretation. Diet is of considerable interest to
rheumatoid arthritis patients but little has been done in the area of etiology. Omega-3
fatty acids have been shown to reduce inflammation and can have a favorable outcome in
those with rheumatoid arthritis. The trace element selenium is low in patients with
rheumatoid arthritis and “although this could be a result of disease activity it might be of
aetiological importance given that selenium probably has antiviral and anti-inflammatory
effects” (Silman and Hochberg 1993:44). The effects o f smoking and rheumatoid
arthritis have been conflicting and no conclusions have been made. Alcohol consumption
was found to be protective against rheumatoid arthritis in women in two studies and
several studies have found that obese individuals were at a higher risk although the “US
Nurses’ Health study found no association between body mass index and RA” (Oilier et
al. 2001:32). Cases o f individuals developing rheumatoid arthritis after having an
infection such as parvovirus and rubella have been documented. Also some
immunizations such as rubella, tetanus and influenza, may have triggered rheumatoid
arthritis in a few patients (Oilier et al. 2001).
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Classification of Rheumatoid Arthritis
Since the etiology of rheumatoid arthritis is unknown, it was necessary to create a
broad description o f the disease to be used for classifying patients to establish uniformity
for studies conducted worldwide. It was not until the first set of criteria for the diagnosis
of rheumatoid arthritis were established in 1958 by the American Rheumatism
Association (formerly the American College of Rheumatology), did a firm definition of
the disease become utilized and accepted worldwide.
Establishing a set o f criteria proved to be a difficult task since many symptoms
are non-specific to rheumatoid arthritis and the cause of the disease has not been
discovered. So the criteria were designed to include a patient in one category or another
rather than for making a firm diagnosis. The diagnostic criteria established in 1958
included three categories o f rheumatoid arthritis: definite, probable and possible. Patients
were assigned to a category based on the number o f criteria they fulfilled (Ropes et al.
1957). Two years later, a revised version of the 1958 criteria were announced adding
another category, classical, which required a patient to fulfill even more criteria to be
considered as having ‘classical rheumatoid arthritis’. The 1958 revised criteria include
the following:
Morning stiffiiess
Pain in at least one joint
Swelling in at least one joint
Swelling in at least two joints
Symmetrical joint swelling
Rheumatoid nodules
X-ray changes
Serum rheumatoid factor
Synovial fluid precipitate
Histological changes in synovium
Histological changes in nodules
13

In 1961, a symposium on Population Studies in Relation to Chronic Rheumatic
Diseases was held in Rome by the American Rheumatism Association to develop another
set o f diagnostic criteria, commonly called the Rome Criteria. The major differences
between the 1961 and 1958 criteria are that the 1961 Rome criteria include a way to
diagnose those patients who have inactive rheumatoid arthritis at the time o f the study
and also eliminate the need to examine histologic changes and synovial fluid which are
both not easily obtained from patients (Bunim et al. 1962). The 1961 Rome criteria
include the following:
Morning stiffness
Pain in at least one joint
Swelling in at least one joint
Swelling in at least two joints
Symmetrical joint swelling
Rheumatoid nodules
X-ray changes
Serum rheumatoid factor
In 1966, a symposium on Population Studies in the Rheumatic Diseases was held
in New York by the American Rheumatism Association to further refine the diagnostic
criteria for rheumatoid arthritis. While trying to establish the new criteria, commonly
called the New York criteria, the scientists “stressed the importance of standardization of
laboratory and radiologic techniques so that subsequent individual comparisons in
longitudinal studies, and group comparisons between different studies could be made
with confidence” (Bennett and Burch 1967:453). Basically the New York criteria laid
out all of the appropriate steps to follow for testing for rheumatoid factor as well as
recommended X-rays that should be taken and the methods to follow. Unfortunately the
1966 New York criteria could not be located.
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And finally, the most recently published diagnostic criteria for rheumatoid
arthritis were developed by the American Rheumatism Association in 1987. Two
decades had passed since the establishment o f the New York criteria in 1966 and
knowledge and understanding o f rheumatoid arthritis had increased since that time
warranting an adjustment once again. Major revisions of the criteria include eliminating
the categories o f ‘classical’, definite’, ‘probable’ and ‘possible’ which seemed to overlap
and falsely diagnose patients, removal of procedures that required invasive techniques
such as synovial biopsy, and an increase in specificity by combining criteria and
decreasing the need for any additional criteria (Amett et al. 1988). The 1987 revised
criteria include the following:
Morning stiffness
Arthritis o f 3 or more joints
Arthritis of hand joints
Symmetric arthritis
Rheumatoid nodules
Serum rheumatoid factor
Radiographic changes
Antiquity of Rheumatoid Arthritis
Rheumatoid arthritis (RA) has become a major health concern across the globe in
the past few decades and has led to a profound interest regarding whether it is a relatively
modem disease (seventeenth century) or whether it substantially predates this estimate.
The consensus appears to be leaning towards a New World origin of some antiquity, but
there is still much to be explored before this debate can be settled or confirmed. Many
scientists have looked towards medical journals and writings o f antiquity, paintings, and
more recently paleopathological finds to help solve these questions, all of which will be
explored in the following paragraphs.
15

Medical Journals and Writings of Antiquity
Several early published medical journals have described many symptoms that are
indicative o f rheumatoid arthritis. These include but are not limited to works by
Sydenham in 1676, Alonso Lopez de Hinojosos in 1578, various works by classical
Greek and Roman authors, Julius Caesar’s chief medical officer Scribonius Largus,
Hippocrates in 460 BC, Galen, and Soranus of Ephesus in the second century (Buchanan
1994; Hochberg et al. 2003; Short 1974). Debate has ensued over who was actually the
first to describe the symptoms o f rheumatoid arthritis but many o f these early writings are
more likely a description o f gout rather than rheumatoid arthritis. O f the medical
writings that were published from the seventeenth century until the present, there is some
agreement that in 1800 Landre-Beauvais was the first to distinguish rheumatoid arthritis
from gout and other rheumatic conditions (Hochberg, et al. 2003). However it did take
several decades for the disease to become clearly defined and even Sir Alfred Baring
Garrod who coined the term ‘rheumatoid arthritis’ in 1859 was still lumping together
osteoarthritis and rheumatoid arthritis in the same category. It was not until the
American Rheumatism Association established a set o f diagnostic criteria for rheumatoid
arthritis in 1958 (discussed above), did a firm definition of the disease become accepted
worldwide.
Paintings
Scientists have also begun to research paintings from Europe dated prior to the
nineteenth century to look for evidence of rheumatoid arthritis. Two earlier examples
from the fifteenth century come from Justus van Gent who painted Federico da
Montefeltro, and Botticelli of a young man, both o f which depict rather disfigured or
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swollen hands. A painting o f Erasmus from Rotterdam in the sixteenth century portrays
swelling o f three metacarpophalangeal joints on his right hand. Although written records
are suggestive of a different rheumatic disease, probably seronegative
spondyloarthropathy. In the seventeenth century a family painting by Jacob Jordaen
includes the maidservant who has swelling o f the metacarpophalangeal and proximal
interphalangeal joints on both hands, very typical of rheumatoid arthritis. Several other
paintings from the sixteenth and seventeenth centuries that may possibly depict
rheumatoid arthritis are ‘Siebrandus Sixtius’, ‘The Temptation o f St. Anthony*, and ‘The
Donators’ (Hochberg et al. 2003). It is also important to note that many o f these
paintings containing possible representations of rheumatoid arthritis may actually be the
artists’ own interpretation or the artistic styles of the period and not medically accurate.
Paleopathological Evidence
Only a short time ago it was accepted that undeniable evidence o f rheumatoid
arthritis had not been found to be present on any skeletal remains before the eighteenth
century. Recent finds from several archaeological excavations have revealed new
information on the history o f this disease. Skeletal remains of archaic Indians from 6500
to 450 BC exhibited symmetrical joint erosions most commonly involving the
metacarpophalangeal, metatarsophalangeal and proximal interphalangeal joints and also
was found in the shoulders and other large joints. As with modem rheumatoid skeletons,
similar erosions were found and women were more commonly affected than men.
Because o f this discovery, it has been proposed that rheumatoid arthritis originated in the
West branch o f the Tennessee River in northwest Alabama and Tennessee because o f the
concentration in this region (Hochberg et al. 2003). A late archaic Indian group from the
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Green River Region in West Central Kentucky dated from 4300 to 4050 years ago was
also found to have symmetrical erosions in the hand and foot joints consistent with a
diagnosis of rheumatoid arthritis (Rothschild and Woods 1990). Rothschild has claimed
that rheumatoid arthritis was “confined to the Tennessee River Valley area until the
Woodland period and only later expands to other parts of North America, and eventually
the world” (Bridges 1992: 84). Contact with European immigrants did not occur in this
region until the eighteenth century, which is consistent with the time rheumatoid arthritis
is to have spread to the Old World (Buchanan 1994).
Bridges argues that the rheumatoid arthritis-like “disease seen in pre-Columbian
America may not have been true RA, but may instead have been caused or triggered by
an infective agent. A variety o f bacterial, viral, and even parasitic diseases have been
known to cause rheumatoid symptoms” (Bridges 1992:84). Another problem is trying to
distinguish rheumatoid arthritis from other arthritic conditions as well as the possibility
that an individual may have more than one condition that may cover up or mask lesions
from rheumatoid arthritis (Merbs 1992). These conjectures make the evidence produced
to date of the existence o f rheumatoid arthritis in the New World thousands of years
earlier than it appeared in the Old World seem less convincing.
Proof of rheumatoid arthritis in Europe before the eighteenth century has been
sparse and difficult to prove, but a lack o f evidence cannot substantiate claims that it did
not exist before that time. In two o f eleven skeletons founds during an excavation o f a
Neolithic burial site (2500 —1900 BC) on the island o f Gotland, Sweden “multiple and
remarkable peripheral articular changes were found” (Leden et al. 1988:342). The
scientists concluded that the skeletons had an arthritic condition that is consistent with
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rheumatoid arthritis, but cannot rule out some other arthritic conditions (Leden et al.
1988). A complete absence o f rheumatoid arthritis in Old World archaeological sites
during the time period corresponding to the Woodland period in North America (Valle de
Petit Morin, France 8000-4000 BP; Tessa Hasar, Iran 7000 BP; Von Luschen’s, Egypt
3000 BP; Negev caves, Israel 1900 BP; Meroitic Nubian, Sudan 1600-1200 BP) helps to
validate the claim that rheumatoid arthritis is a New World disease (Rothschild and
Woods 1992).
After reviewing the evidence from written records, works of art and skeletal
remains, it appears as though rheumatoid arthritis is not a new disease and may have
originated before the eighteenth century, at least in the New World. As to whether it was
present in the Old World before the eighteenth century is less clear, as the evidence
gathered to date is rather limited.
Conclusion
Rheumatoid arthritis is a multifaceted disease that is largely misunderstood by the
public who usually confuse it with osteoarthritis or degenerative joint disease.
Unfortunately much of the etiology of rheumatoid arthritis is unknown by researchers and
rheumatologists as well. This lack of knowledge and the increasing number of people
afflicted with the disease has initiated many studies, such as the present study, in search
o f clues to help us understand this complex disease.
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Hypotheses
Hypothesis 1: The prevalence of rheumatoid arthritis will be lower among the ancestral
groups o f North American when compared to ancestral groups living on other continents
due to the advanced health care available in North America, and more specifically the
United States.
Hypothesis 2: The prevalence of rheumatoid arthritis can be partially explained by
carefully selected economic and demographic variables for each country addressed in this
study.
Hypothesis 3: Studies conducted on the prevalence of rheumatoid arthritis will be
influenced by factors that are often not given adequate consideration.
Sum m ary of C hapters
This paper is divided into five parts. Chapter I, the current chapter, provides an
introduction to this study and goals of the research. Statistics on the burden of
rheumatoid arthritis and the growing interest by several organizations are also included to
establish the necessity of the present study. In addition. Chapter I provides a detailed
literature review to provide a general understanding o f what rheumatoid arthritis is, how
it may develop, the disease process, and whom it affects. This is broken down into
sections examining the clinical features and diagnosis, pathology, etiology, classification,
and antiquity o f rheumatoid arthritis. Chapter II begins with a review of the criteria
established to make the comparison of data more reliable and consistent. An explanation
about the placement o f each population into an established ancestral group and subgroup
is also given. This is necessary to provide the reader with some insight into why certain
populations were grouped together. In addition. Chapter II introduces the data and
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statistics used in the present study, most of which were obtained from the CIA World
Factbook online. This is presented in the form of tables and figures. Chapter III applies
a statistical analysis to the data introduced in Chapter II. Chapter IV discusses how the
prevalence of rheumatoid arthritis varies between different parts of the world and is
influenced by economics, cultural values, communication, and expectations. Chapter V
presents a summary and conclusion regarding the factors discussed in Chapter IV and
how the prevalence studies included here may have been affected as a result of these
factors.
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CHAPTER II
MATERIALS AND METHODS
Many prevalence studies have been conducted all over the world, but to date none
have specifically compared the United States with other countries. This is surprising
since studies on geography and prevalence o f rheumatoid arthritis have been carried out
for over 40 years. The present chapter begins to address this gap in information.
Prevalence versus Incidence
Before beginning the research phase, it was necessary to determine which
measurement was most appropriate for the goal of the present study, prevalence or
incidence. The World Health Organization has conducted many prevalence studies on
rheumatoid arthritis in countries where such data was previously lacking, hoping to fill
the gap in information. Many studies have also been performed on the incidence of
rheumatoid arthritis, which measures “the number o f new cases of a disease in a
population over a period of time” (Mausner and Bahn 1974:126). While this is of some
significance, the prevalence rate is the first factor to take into account when considering
the importance of medical issues and is described as a measure o f “the number of people
in a population who have the disease at a given point in time” (Mausner and Bahn
1974:127). Prevalence is also more suited for the present study because it
“depends on two factors: how many people have become ill in the past and the
duration o f their illnesses. Even if only a few people in a group become ill each
year, if the disease is chronic the number will mount and the prevalence will be
relatively large in relation to incidence. On the other hand, if the illness under
consideration is o f short duration (acute) because o f either recovery or death, or if
there is migration o f ill persons from the area, then prevalence will be relatively
low” (Mausner and Bahn 1974:127).
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In summary, “prevalence is affected by factors which influence the duration o f a
disease as well as its development” (Mausner and Bahn 1974:128), which in the present
study will be higher than incidence since rheumatoid arthritis is a chronic disease that is
rarely fatal. A higher rate may also cause differences and similarities in prevalence to
stand out more abruptly.
Criteria
A vast amount o f published literature addresses the prevalence o f rheumatoid
arthritis in countries from all parts of the world. Scientists are looking at several
populations because they are interested in studying how rheumatoid arthritis affects
different populations living in different environments. This study addresses this issue as
well. To make a comparison of the literature more reliable and consistent for this study,
six criteria were established.
The first criterion is that each study must have adhered to the American
Rheumatism Association (formerly American College of Rheumatology) diagnostic
criteria for rheumatoid arthritis. Either the 1958, 1961, 1966 or 1987 versions can be
used. All have similar criteria and overlap in many respects, each becoming more
straightforward and refined for easier replication for use in population studies. The
second criterion is each study must encompass a broad age range to ensure a
representative sample o f the entire population. If the age range is too narrow, the
prevalence may be much higher than those that have a much more broad age range and
may skew the results when comparing studies. The third criterion is the sample
population used in each study must be random or household-to-household to ensure a
representative sample of the total population of the area defined. Those studies that rely
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only on medical records from local hospitals are biased towards those that seek medical
attention. They neglect the portion o f the population that cannot afford to seek such
medical services or do not seek medical care for other reasons. In many developing
countries those that do not seek medical attention could account for a majority of the
population. Even in the United States this may represent a significant amount o f the
population. The fourth criterion to be included is each study must identify the population
they are studying. If more than one population is being examined in a study then
percentages of racial/ethnic groups must be presented and the prevalence o f rheumatoid
arthritis must be given for each. The fifth criterion is each study must include the number
of individuals represented in the study and the number of individuals found to have
rheumatoid arthritis. This information is crucial in order to obtain an accurate average
for each subgroup and country or population with multiple prevalence rates. Finally the
last criterion is each study must have utilized x-rays and serological tests to help confirm
the diagnosis of rheumatoid arthritis. X-rays are needed in order to look for joint
involvement or find rheumatoid nodules. Serological tests are necessary to test for
rheumatoid factor on at least a portion o f the individuals involved in the study to further
establish the presence or absence o f the disease in certain individuals. The need for xrays and serological tests is included in the diagnostic criteria discussed later in this
chapter, yet some studies fail to perform these tests because of cost or inconvenience.
Once these six criteria were applied to each o f the 86 studies that were discovered during
the research phase, the number was reduced to 34. Each o f the 34 population studies
included follow similar procedures and guidelines to warrant a sound comparison
between them. Those that did not meet just one o f the six criteria were excluded from
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this study. A majority of the prevalence studies on rheumatoid arthritis were not included
because they did not meet all o f the criteria established for the present study. Some of
these may have actually met all of the criteria but were too vague and excluded some
necessary information. For further details on the methods used in each study, the papers
by the original authors should be consulted (see References Cited).
Patient Assessment
In order for a population study to be included in the present study, a clinical,
radiological, and serological assessment had to have been described in the published data,
as discussed above under criterion six. Not all o f the participants surveyed for each study
were assessed and a legitimate reason must have been provided to explain why some
participants did not undergo a full clinical, radiological and serological assessment.
Some studies neglected to provide such information and were therefore excluded from
the present study. The following describes what is involved in each assessment.
Clinical Assessment
Every prevalence study included in the present study performed a clinical
assessment of each patient to determine whether or not they have rheumatoid arthritis.
This examination was usually held in a patient’s home while conducting a household-tohousehold survey. Healthcare workers, nurses and/or rheumatologists, who attended a
training course on the proper procedures to conduct consistent interviews and
examinations o f each patient, usually conducted the clinical assessment. The clinical
assessment usually included an examination of the hands and/or feet for signs o f tender or
swollen joints. A personal interview with each patient was conducted as well to assess
their overall condition.
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Radiological Assessment
A radiological assessment needed to be performed to be included in the present
study. Most of these examinations were conducted in patient’s homes, although some of
the studies required participants to visit a clinic or hospital for evaluation. At least half
o f the patients in each study or those that required further evidence of rheumatoid arthritis
had x-rays taken o f the hands and/or feet with some including larger joints as well. The
Atlas o f Standard Radiographs o f Arthritis was used in many o f the studies to assess the
grade or severity of deformity o f the joints. This also helped to establish some
consistency between studies when reading radiographs.
Serological Assessment
Finally, a serological assessment needed to be performed to be included in this
study. As with the radiological assessment, most of the serological tests were conducted
in patient’s homes, although some studies required attendance at a local clinic or hospital.
At least half of the patients or those that required further evidence to demonstrate the
presence of rheumatoid arthritis had serological tests in each study. Serological tests
were mainly performed to test for the presence o f rheumatoid factor although some
studies included results o f tests associated with rheumatoid arthritis but not an indicator
for it. Some of the tests that indicate the presence of rheumatoid factor include the
bentonite flocculation test (BFT), the human erythrocyte agglutination test (HEAT), the
latex fixation test (LFT), and the sheep cell agglutination test (SCAT). The use of any
one o f these tests allowed a prevalence study to be included in the present study.
Table 2.1 lists each prevalence study that met all of the criteria discussed above
and as a result was included in the present study. Information about each study including
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the country or population, year of the American Rheumatism Association diagnostic
criteria used, age of the population surveyed, how the sample population was surveyed,
the prevalence of rheumatoid arthritis, and the author(s) are given.
Table 2.1 —Prevalence Studies
Prevalence
C ountry
C riteria Age Sample
o fR A (% )
Author(s)
South Africa
1961
15+ Random
0.87
Beighton et al
South Africa
1961
18+ Random
2.2
Meyers et al
South Africa
1961
15+ Random
3.3
Solomon et al
Nigeria
1987
15+ Random
0
Silman et al
Lesotho
1961
15+ Random
1.8
Moolenburgh et al
United States
1958 18-79 Random
3.1
US Dept of Health
Ireland
1987
18+ Random
0.5
Power et al
Lawrence
England
1958
15+ Random
4.3
Carmona et al
Spain
1987
20+ Census
0.5
1.2
Symmons et al
United Kingdom 1987
16+ Random
Malaviya et al
1987
17+ Household
0.75
India
AI Rawi et al
16+ Random
1.3
Iraq
1956
Household
0.36
Fountain
1987
16+
Oman
Farooqi and Gibson
0.55
Pakistan
1987
15+ Household
0.14
Hameed and Gibson
1958
16+ Random
Pakistan
0.22
AI Dalaan et al
1987
16+ Random
Saudi Arabia
Senna et al
0.62
1987
17+ Random
Brazil
2.7
Llerena et al
17+ Stratified
Cuba
1987
Mendez-Bryan et al
0.92
1958
15+ Total
Puerto Rico
3.2
US
Dept of Health
Random
United States
1958 18-79
0.34
Wigley et al
20+ Register
China
1958
Wigley et al
0.32
China
1958
20+ Register
Chou et al
0.26
Taiwan
1958
20+ Random
0.78
Chou et al
20+ Random
Taiwan
1958
Chou et al
0.93
Taiwan
1958
20+ Random
Lau et al
17+ Household
0.35
China
1987
Dai et al
0.47
China
1987
16+ Random
1987
Hoa et al
Vietnam
16+ Random
0.28
1961
18+ Household
Beasley et al
China
0.3
1961
Shichikawa et al
15+
Random
Japan
0.3
1956
15+ Total
Darmawan et al
Indonesia
0.4
1987 15-90 Random
Thailand
0.12
Chaianmuay et al
1958
18+ Members
Chippewa
7.1
Harvey et al
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Eskimos
Eskimos
Eskimos
Eskimos
Blackfeet
Pima
Pima
Pima
Pima
Pima
Pima
Pima
United States

1987
1987
1987
1987
1958
1958
I96I
1958
1958
1958
I96I
1966
1958

20+
20+
20+
20+
30+
30+
20+
15+
15+
15+
15+
15+
18-79

1.4
0.6
1.5
0.5
4.1
5.4
5.3
3.3
2.75
2.05
5.2
5.9
4.8

Register
Register
Register
Register
Total
Total
Total
Total
Total
Total
Total
Total
Random

Boyer et al
Boyer et al
Boyer et al
Boyer et al
Bunim et al
Bunim et al
Del Puente et al
Jacobsson et al
Jacobsson et al
Jacobsson et al
Henrard et al
Henrard et al
US Dept of Health

Ancestral G roup and Subgroup Division
In order to make analysis possible, each population o f study had to be placed into
specified ancestral groups of Caucasoid, Negroid or Mongoloid (Bass 1995). These
ancestral groups are already well-established anthropological terms and are based on
geographical origins, not skin color (White 2000). They are often used for human
identification and are appropriate for the present study to distinguish populations of
individuals. In keeping with the terms of this study, each ancestral group was further
divided into two subgroups based on where each population study was held. These
subgroups are North America and non-North America for each ancestral group.
Population studies included in the Caucasoid group include the following
countries: Ireland, England, Spain, United Kingdom, India, Iraq, Oman, Pakistan, Saudi
Arabia, Cuba, Puerto Rico, Brazil, and the United States. These were further subdivided
into two categories: North America and non-North America. Cuba, Puerto Rico and the
United States are included in the North American subgroup. Cuba’s population as stated
in the prevalence study conducted there, was 72.6 percent white (Caucasoid). Puerto
Rico’s population according to the CIA World Factbook for 2004 is 80.5 percent white
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(Caucasoid). Those numbers are high enough to be included in the Caucasoid North
American subgroup. Ireland, England, Spain, United Kingdom, Brazil, India, Iraq,
Oman, Pakistan and Saudi Arabia are part of the non-North American subgroup. India’s
population presented in the study conducted there was considered to be more closely
related to Caucasoid and so it is included in the Caucasoid non-North American
subgroup (Malaviya et al. 1993). Brazil’s population according to the CIA World
Factbook for 2004 is 55 percent white (Caucasoid) and 38 percent mixed black (Negroid)
and white (Caucasoid), adequate to be included in the Caucasoid group. The most
logical ancestral group category to place Iraq, Oman, Pakistan and Saudi Arabia seemed
to be Caucasoid for they share the closest affinity (Quintana-Murci et al. 2004).
Population studies included in the Negroid group include the following countries:
South Africa, Nigeria, Lesotho and the United States. These were further subdivided into
two categories: North America and non-North America, Only one study conducted in the
United States is included in the Negroid North American subgroup. The studies
conducted in Nigeria, Lesotho and South Africa are part of the non-North American
subgroup.
Population studies included in the Mongoloid group include the following
countries: Vietnam, Thailand, Indonesia, Japan, Taiwan, China, and will all be contained
within the subgroup of Mongoloid non-North American, Other population studies that
will be included in the Mongoloid group include: Chippewa, Eskimos, Blackfeet, Pima,
and the United States, which are all part o f the subgroup o f Mongoloid North American,
The decision was made to classify Native Americans as part o f the Mongoloid ancestral
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group because they are the likely closest genetic match, as Native Americans are thought
to have originally migrated from Asia to North America (Dugoujon et al. 2004).
Table 2.2 is a list of each country or population used in this study along with the
corresponding prevalence for each. Although 46 prevalence scores are listed only 34
studies were actually used. This difference is due to the fact that some studies were
conducted on more than one population or were done at several intervals over many years
giving multiple results. The ancestral group for which each country or population has
been assigned is also listed. As discussed above, the ancestral groups are Negroid,
Caucasoid, and Mongoloid. Along with the ancestral group, the two subgroups to which
each population is assigned are also given which include North American and non-North
American.
Table 2.2 —G roups and Subgroups
Prevalence
of RA (% )
Country
0.87
1 South Africa
2.2
2 South Africa
3.3
3 South Africa
0
4 Nigeria
1.8
5 Lesotho
3.1
6 United States
0.5
7 Ireland
4.3
8 United Kingdom
0.5
9 Spain
1.2
10 United Kingdom
0.75
11 India
1.3
12 Iraq
Oman
0.36
13
0.55
14 Pakistan
0.14
15 Pakistan
0.22
16 Saudi Arabia
0.62
17 Brazil
2.7
18 Cuba

Ancestral
G roup
Negroid
Negroid
Negroid
Negroid
Negroid
Negroid
Caucasoid
Caucasoid
Caucasoid
Caucasoid
Caucasoid
Caucasoid
Caucasoid
Caucasoid
Caucasoid
Caucasoid
Caucasoid
Caucasoid
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Subgroup
non-North American
non-North American
non-North American
non-North American
non-North American
North American
non-North American
non-North American
non-North American
non-North American
non-North American
non-North American
non-North American
non-North American
non-North American
non-North American
non-North American
North American
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20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46

Puerto Rico
United States
China
China
Taiwan
Taiwan
Taiwan
China
China
Vietnam
China
Japan
Indonesia
Thailand
Chippewa
Eskimos
Eskimos
Eskimos
Eskimos
Blackfeet
Pima
Pima
Pima
Pima
Pima
Pima
Pima
United States

0.92
3.2
0.34
0.32
0.26
0.78
0.93
0.35
0.47
0.28
0.3
0.3
0.4
0.12
7.1
1.4
0.6
1.5
0.5
4.1
5.4
5.3
3.3
2.75
2.05
5.2
5.9
4.8

Caucasoid
Caucasoid
Mongoloid
Mongoloid
Mongoloid
Mongoloid
Mongoloid
Mongoloid
Mongoloid
Mongoloid
Mongoloid
Mongoloid
Mongoloid
Mongoloid
Mongoloid
Mongoloid
Mongoloid
Mongoloid
Mongoloid
Mongoloid
Mongoloid
Mongoloid
Mongoloid
Mongoloid
Mongoloid
Mongoloid
Mongoloid
Mongoloid
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North American
North American
non-North American
non-North American
non-North American
non-North American
non-North American
non-North American
non-North American
non-North American
non-North American
non-North American
non-North American
non-North American
North American
North American
North American
North American
North American
North American
North American
North American
North American
North American
North American
North American
North American
North American

Figure 1 shows the mean prevalence for each country and population used in this
study. Countries and populations that have multiple studies conducted are represented
by the average of those scores. As shown in Table 2.2, some groups and subgroups are
well represented with several different studies contributing to the average, while others
may contain only one study or prevalence score making the average less reliable.
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Figure 1 - Average Prevalence of RA per Country/Population
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Table 2.3 lists the six ancestral group and subgroup combinations and the average
prevalence of rheumatoid arthritis for each.

Figure2displaysthe difference in

prevalence of rheumatoid arthritis for each of the six groups/subgroups. The prevalence
for each group/subgroup is the average of all the scores for that grouping.
Table 2.3 —Prevalence of RA per Group/Subgroup
Ancestral Group / Subgroup
Caucasoid non-North American
Caucasoid North American
Mongoloid non-North American
Mongoloid North American
Negroid non-North American
Negroid North American

Prevalence
(%)
0.8
2.4
0.4
3.8
1.1
3.1

4) 2.0

1

C a u c a so id
non-N oith
A m erican

C au ca so id
North
A m erican

Mongoloid
non-N orth
A m erican

I

Mongoloid Negroid nonN oilh
North
A m erican
A m erican

Subgroup

Figure 2 —Average Prevalence of RA per Group/Subgroup
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Economie and Demographic Data
It initially appears as though there is an increased prevalence of rheumatoid
arthritis in every ancestral group for North America, as compared to non-North American
ancestral groups. But the prevalence rate is not telling the whole story of rheumatoid
arthritis. There is more to this matter than simply claiming that Americans have an
increased prevalence of rheumatoid arthritis. Various economic and demographic issues
for each population must be considered when assessing these differences in prevalence.
Numerous statistics and data are available for almost every country in the world,
but for the present study only a few select economic and demographic variables are
needed. The variables consist o f the gross domestic product - per capita, the life
expectancy o f the total population, the age structure of the population, and the percentage
of the population below the poverty line. These were chosen because they measure the
quality o f life in a country and can affect key socioeconomic issues (www.cia.gov 2004).
Table 2.4 is a list o f all the countries included in this study and the gross domestic
product - per capita for each of those countries as stated by the CIA World Factbook for
2004. Figure 3 displays the gross domestic product - per capita for each country used in
this study.
Table 2.4 —Gross Domestic P roduct-per capita
(Source: 2004 CIA World Factbook)

1
2
3
4
5
6

C ountry
Ireland
Spain
United Kingdom
India
Iraq
Oman

G D P-per
capita
29,800
22,000
27,700
2,900
1,600
13,400
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7
8
9
10
11
12
13
14
15
16
17
18
19
20
21

Pakistan
Saudi Arabia
Brazil
Cuba
Puerto Rico
United States
South Afi*ica
Nigeria
Lesotho
China
Taiwan
Vietnam
Japan
Indonesia
Thailand

2,100
11,800
7,600
2,800
16,800
37,800
10,700
800
3,000
5,000
23,400
2,500
28,000
3,200
7,400

4 0 ,0 0 0 -
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Figure 3 —Gross Domestic Product-per capita for each country
(Source: 2004 CIA World Factbook)
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Table 2.5 lists each country used in this study and the life expectancy calculated
for the total population of men and women according to the CIA World Factbook for
2004. Figure 4 compares the life expectancy for the total population for each country
used in this study.
Table 2.5 —Life Expectancy of the Total Population
(Source: 2004 CIA World Factbook)

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21

Country
Ireland
Spain
United Kingdom
India
Iraq
Oman
Pakistan
Saudi Arabia
Brazil
Cuba
Puerto Rico
United States
South Africa
Nigeria
Lesotho
China
Taiwan
Vietnam
Japan
Indonesia
Thailand

Life Expectancy (Total
Population)
77.36
79.37
78.27
63.99
68.26
72.85
62.61
75.23
71.41
77.04
77.49
77.43
44.19
50.49
36.81
71.96
77.06
70.35
81.04
69.26
71.41
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Figure 4 —Life Expectancy of the Total Population for each country
(Source: 2004 CIA World Factbook)
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Table 2.6 is a breakdown of how the population is distributed according to age.
The percent of the population for three age groups, 0-14 years, 15-64 years, and 65+
years, for each country included in this study is listed. These statistics are also taken
from the CIA World Factbook for 2004. Figure 5 shows the distribution of the
population according to age for each country included in this study.
Table 2.6 —Age Structure of the Population
(Source: 2004 CIA World Factbook)

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21

C ountry
Ireland
Spain
United Kingdom
India
Iraq
Oman
Pakistan
Saudi Arabia
Brazil
Cuba
Puerto Rico
United States
South Africa
Nigeria
Lesotho
China
Taiwan
Vietnam
Japan
Indonesia
Thailand

Age 0-14
(% )
21
14.4
18
31.7
40.3
42.4
40.2
38.3
26.6
20
22.4
20.8
29.5
43.4
37-3
22.3
19.9
29.4
14.3
29.4
24.1

Age 15-64
(% )
67.5
68
66.3
63.5
56.7
55.1
55.8
59.3
67.6
69.8
65.4
66.9
65.3
53.7
57.2
70.3
70.7
65
66.7
65.5
68.7
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Age 65+
(% )
11.5
17.6
15.7
4.8
3
2.5
4.1
2.3
5.8
10.1
12.2
12.4
5.2
2.9
5.5
7.5
9.4
5.6
19
5.1
7.3

■ Age 0-14 (%)
■ Age 15-64 (%)
□ Age 65+ (%)
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Figure 5 - Age Structure of the Population for each country
(Source: 2004 CIA World Factbook)
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Table 2.7 includes the percentage o f the population below the poverty line for
each country included in this study. These statistics are taken from the CIA World
Factbook for 2004 and do not specify what the poverty line is estimated to be for each
country. The Factbook only states that the “definitions o f poverty vary considerably
among nations” and “rich nations generally employ more generous standards of poverty
than poor nations” (www.cia.gov 2004). Unfortunately information was not available for
several countries used in the present study. Spain, Iraq, Oman, Saudi Arabia, Cuba,
Puerto Rico and Japan had no data on the percent o f the population below the poverty
line and are shown as (NA). Figure 6 compares the percentage of the population below
the poverty line for each country included in the present study. The countries of Spain,
Iraq, Oman, Saudi Arabia, Cuba, Puerto Rico and Japan are included, but show a value of
zero because of lack of information.
Table 2.7 —Percentage of the Population Below the Poverty Line
(Source: 2004 CIA World Factbook)
Population below poverty line
C ountry
(% )
10
1 Ireland
NA
2 Spain
17
3 United Kingdom
25
4 India
NA
5 Iraq
NA
6 Oman
35
7 Pakistan
NA
8 Saudi Arabia
22
9 Brazil
NA
10 Cuba
NA
II Puerto Rico
12
United
States
12
50
13 South Africa
14 Nigeria
60
49
15 Lesotho
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16
17
18
19
20
21

China
Taiwan
Vietnam
Japan
Indonesia
Thailand

10
1
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Figure 6 —Percentage of the Population Below the Poverty Line for each country
(Source: 2004 CIA World Factbook)
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Conclusion
It is evident from Figure 2 that there is an increased prevalence of rheumatoid
arthritis in the three ancestral groups that make up the North American subgroup. To
explain this phenomenon, several economic and demographic variables were provided for
each country involved in the present study. These variables, taken from the CIA World
Factbook for 2004, include the gross domestic product (GDP) per capita, life expectancy
of the total population (men and women combined), the age structure o f the population,
and the percentage o f the population below the poverty line. Chapter III will analyze
these variables.
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CHAPTER III
RESULTS
The present chapter will examine the statistics for gross domestic product - per
capita, life expectancy o f the total population (men and women), the percentage o f the
population 65 years and older, and the percentage of the population below the poverty
line presented in Chapter II. All four o f these variables may potentially contribute to the
outcome o f the prevalence rates of rheumatoid arthritis for each country included in the
present study, although to what degree is not fully understood. To help establish a
relationship between the prevalence of rheumatoid arthritis and the four variables, the top
five highest and lowest values were tallied for the first three variables just mentioned.
The results are as follows:
Table 3.1 - Top Five High/Low values for GDP p er capita. Life Expectancy, and %
of the Population 65+
GDP-oer caoita
Hieh
Low
Ireland
Iraq
Pakistan
UK
Cuba
US
Taiwan
Nigeria
Vietnam
Japan

Life exDectancv
High
Low
Spain
India
UK
Pakistan
Puerto Rico S. Africa
US
Nigeria
Jap an
Lesotho

% PoDulation 65+
Low
Hieh
Iraq
Spain
Oman
UK
Pakistan
Puerto Rico
Saudi Arabia
US
Nigeria
Jap an

In Table 3.1, the countries that are highlighted in bold print are found consistently
in all three variables. This includes the United Kingdom, the United States and Japan for
the highest values for each of the variables, and Pakistan and Nigeria for the lowest
values. The countries that are found in at least two o f the variables are italicized and
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include Spain and Puerto Rico for the highest values and Iraq for the lowest value. Next,
the prevalence o f each of these countries is applied.
Table 3.2 - Prevalence of RA for the Countries with the Highest and Lowest Values
High
Prevalence
United Kingdom
2.1
United States
3.7
Japan
0.3
Spain
0.5
Puerto Rico
0.92

Low
Prevalence
Pakistan
0.27
Nigeria
0
Iraq
1.3

As shown in Table 3.2, for the five countries that most consistently have the
highest values, the prevalence rate of rheumatoid arthritis ranges from 0.3 percent to 3.7
percent. The three countries that most consistently have the lowest values have a
prevalence rate of rheumatoid arthritis ranging from 0.0 percent to 1.3 percent. It appears
as though the prevalence o f rheumatoid arthritis can vary substantially despite
commonalities shared between countries and is not influenced by any of the three
variables above. To further establish what appears to be an absence of a relationship, the
Pearson Correlation Test was performed for gross domestic product - per capita, life
expectancy of the total population, and the percentage of the population 65 years and
older. The results are given below in Table 3.3.
Table 3.3 —Pearson C orrelation Test Results
G DP-per capita Life expectancy Age 65+ (% )
Prevalence of
Pearson Correlation
RA (% )
Sig. (2-tailed)
N

0.420
0.058
21
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Figure 7 —Scatterplots of the Pearson Correlation Test Results
According to Table 3.3, the correlation between the prevalence of rheumatoid
arthritis and gross domestic product - per capita, life expectancy of the total population,
and the percentage of the population age 65 years and older, are not significant at the .01
and .05 levels. Figure 7 plots the prevalence of rheumatoid arthritis against the three
variables. Many of the points appear to be rather random with several outliers. The
absence of a relationship between the prevalence of rheumatoid arthritis and gross
domestic product - per capita, life expectancy of the total population, and percentage of
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the population 65 years and older, is further established by the r^ values (0.176; 0.003;
0.064) shown in the small boxes within each scatterplot. Therefore, no pattern or
relationship is yet evident between prevalence rate o f rheumatoid arthritis and economic
and demographic standing for the countries included in this study. Next the subgroup in
which each country has been placed will be applied to further attempt to establish a
relationship.
Table 3.4 —Group/Subgroup and Prevalence of RA for High/Low Countries
Country
Group/Subgroup
Prevalence High/Low
2.1
United Kingdom Caucasoid non-North American
2.1
High
0.5
Spain
Caucasoid non-North American
High
0.27
Low
Pakistan
Caucasoid non-North American
1.3
Low
Iraq
Caucasoid non-North American
3.7
High
United States Caucasoid North American
0.92
High
Puerto Rico
Caucasoid North American
0.3
High
Japan
Mongoloid non-North American
0
Low
Nigeria
Negroid non-North American
In Table 3.4 it appears as if there is no relationship evident between the
prevalence of rheumatoid arthritis, group/subgroup, and economic and demographic
standing. The five countries with highest values in the above variables represent three
subgroups {Caucasoid non-North American, Caucasoid North American, Mongoloid nonNorth American) and the three countries with lowest values represent two subgroups
{Caucasoid non-North American, Negroid non-North American). The four countries
represented in the Caucasoid non-North American subgroup have prevalence rates of
rheumatoid arthritis o f 0.27, 0.5, 1.3 and 2.1 percent. O f these, there are two high and
two low values for the variables discussed above. Unfortunately the high and low values
each represent a high and low prevalence o f rheumatoid arthritis (0.27%-Low; 0.5%46

High; 2.1%-High; 1.3%-Low). The three other subgroups {Caucasoid North American,
Mongoloid non-North American, Negroid non-North American) shown in Table 3.4 do
not have enough data to attempt to formulate a pattern. In addition, no correlation test
could be performed due to the lack o f numerical data sets in Table 3.4.
Next, the percentage of the population below the poverty line will be applied.
These numbers can only loosely be associated since statistics for several countries were
unavailable including four (Spain, Iraq, Puerto Rico, Japan) of the eight that have the top
high and low values. The low and high values in this case indicate the opposite of the
three variables discussed previously.
Table 3.5 —Top Five Low/High Values for the Percentage of the Population Below
the Poverty Line
% Population below povertv line
Low
High
Ireland
Pakistan
US
South Africa
China
Nigeria
Taiwan
Lesotho
Thailand
Vietnam
Again in Table 3.5, the United States has one o f the lowest values and Pakistan
and Nigeria come in with some of the highest values. Unfortunately this reveals little
more information. As was done with the previous three variables, the Pearson
Correlation Test was performed to further establish what appears to be the absence of a
relationship between the prevalence o f rheumatoid arthritis and the percentage of the
population below the poverty line.
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Table 3.6 —Pearson Correlation Test Results

Below poverty
line (% )
Prevalence of RA
(% )

€

Pearson Correlation
Sig. (2-tailed)
N

-0.055
0.853
14

30 0 -

0 00

Figure 8 —Scatterplot of the Pearson Correlation Test Results
In Table 3.6 the correlation between the prevalence of rheumatoid arthritis and the
percentage of the population below the poverty line is not significant at the .01 or .05
levels, further proving a lack of association between them. Figure 8 plots the prevalence
of rheumatoid arthritis against the percentage of the population below the poverty line.
As with the other three variables discussed above, the points appear to be random with
many outliers. What appears to be an absence of a relationship is further established by
the r^ value of 0.003 shown in the small box within the scatterplot.
Unfortunately this has demonstrated that individually the correlation between the
four variables and prevalence of rheumatoid arthritis is insignificant and that there are
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some other underlying factors influencing the prevalence rate of rheumatoid arthritis in
the studies included here, so a different approach was needed. A correlation test was
performed between each o f the four variables (gross domestic product - per capita, life
expectancy o f the total population, percentage o f the population 65 years and older,
percentage o f the population below the poverty line) excluding the prevalence of
rheumatoid arthritis.
Table 3.7 —Pearson Correlation Test Results excluding the Prevalence of RA

Age 65+ (% )
0.550**
Life expectancy Pearson Correlation
0.010
Sig. (2-tailed)
21
N
0.521*
GDP-per capita Pearson Correlation
0.015
Sig. (2-tailed)
21
N
Below poverty
Pearson Correlation
-0.655*
line (% )
0.011
Sig. (2-tailed)
14
N
** Correlation is significant at the 0.01 level (2-tailed)
* Correlation is significant at the 0.05 level (2-tailed)
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Below poverty
line (% )
-0.864**
0
14
-0.584*
0.028
14

GDP-per
capita
0.447*
0.042
21

^ 6 0 00«
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Figure 9 —Scatterplots of the significant results of the Pearson Correlation Test at
at the .01 level
As shown in Table 3.7, all combinations bad significant correlation results, but
only two bad significant results at the .01 level. There is a positive correlation between
the life expectancy of the total population, and the percentage of the population 65 years
and older (r = 0.550, p = 0.010). This is simply saying the greater the life expectancy of a
population, the larger the population 65 years and older will be. There is a negative
correlation between life expectancy and the percentage of the population below the
poverty line (r = -0.864, p = 0.000). This is more significant than the previous case.
Basically it is stating that the greater the number of individuals in poverty, the lower the
life expectancy they will have. Figures 9 plots each of the significant results at the .01
level shown in Table 3.7. The points appear to be less random with fewer outliers, unlike
Figures 7 and 8. As demonstrated in Table 3.7 the relationship between these variables is
significant and can be further established by the r^ values of 0.302 and 0.746 respectively.
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Conclusion
Although the prevalence o f rheumatoid arthritis has been shown to be
uninfluenced by gross domestic product-per capita, life expectancy o f the total
population, the percentage o f the population 65 years and over, and the percentage of the
population below the poverty, the four variables do show significance when compared
with each other. They may not be a direct indication o f what the prevalence of
rheumatoid arthritis may be in a population, but they do suggest much about how
rheumatoid arthritis and other diseases may be handled and treated in that country.
Chapter IV will further discuss the impact of the four variables on the prevalence of
rheumatoid arthritis and explore other explanations that may have influenced the outcome
of the prevalence studies included here.
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CHAPTER IV
DISCUSSION
In the previous chapter, the four variables (gross domestic product - per capita,
life expectancy of the total population, the percent of the population sixty-five years and
older, and the percentage o f the population below the poverty line) were examined. The
goal of this chapter is to discuss the results o f those variables and explore other
explanations such as access to medical care, cultural values, communication, and
expectations that may clarify the difference in prevalence o f rheumatoid arthritis between
North American and non-North American populations. This chapter will begin with a
discussion o f the economic and demographic statistics presented in Chapters II and III.
Economic and Demographic Statistics
The gross domestic product-per capita has shown to be the best predictor of the
prevalence of rheumatoid arthritis among the four variables examined in Chapter III (see
Table 3.3), but probably does not contribute to the differences between
countries/populations. Table 2.4 and Figure 3 in Chapter II show the substantial
differences among the countries included in this study and Figure 7 in Chapter III
illustrates the randomness and lack of relationship between the two variables. While the
gross domestic product-per capita o f a country cannot predict whether a population will
have a high or low prevalence o f rheumatoid arthritis, it can provide insight into the
availability of health care and medical services. Each country has limited resources for
health care and how these resources are allocated can greatly affect the care that patients
receive. Access to and availability of health care can play a large role in the outcome of
rheumatoid arthritis in a population (discussed in detail below).
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The age structure of the population could also potentially contribute to the
difference in prevalence rates between countries/populations. Yet as demonstrated in
Chapter III, Table 3.3 and Figure 9, this is not the case with the countries included in this
study. The correlation between the percentage o f the population 65 years and over and
the prevalence o f rheumatoid arthritis is insignificant and appears to be unrelated. As
shown in Chapter II, Table 2.6 and Figure 5, the age structure for each country varies
quite substantially for all three age groups. This is important because a large elderly
population (65 years of age and greater) or a large population under 15 years of age will
have the tendency to dramatically change the prevalence rate of rheumatoid arthritis for
that population. This is due to the fact that rheumatoid arthritis usually has an onset
during adulthood. The age structure o f a country can also reveal where its economic
issues may lie. For instance, if a country has a large elderly population, more money may
be devoted towards health care and providing medical services for the aging population.
On the other hand, if a country has a large youth population, then more money may be
invested into education, and health care may be neglected (www.cia.gov 2004).
The life expectancy of a population may also affect the prevalence o f rheumatoid
arthritis. As with the age structure of the population, the smaller the percentage of older
individuals that make up the population, the lower the prevalence o f rheumatoid arthritis
should be. As shown in Table 2.5 and Figure 4 o f Chapter II, the life expectancy varies
greatly for each country ranging from less than 40 years to over 80 years. Unfortunately
for this study, life expectancy has not been shown to be a good predictor of the
prevalence o f rheumatoid arthritis in a population. Chapter III, Table 3.3 and Figure 8
illustrate the lack o f relationship between the two variables. The life expectancy for an
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individual can have a lot to do with social, political and economic conditions, but is also
affected by behavioral choices such as diet and exercise, as well. As people live longer,
they are more likely to experience problems with human mechanics and functions, body
parts begin to deteriorate or break down resulting in a variety of disorders. This has
affected individuals in developed countries for decades. It has only recently become an
issue in developing countries as their population has begun to develop chronic diseases
due to recent improvements in health care.
The percentage o f the population below the poverty line may also potentially
contribute to the difference in prevalence o f rheumatoid arthritis between countries.
Poverty is typically measured in terms of income. As shown in Chapter II, Table 2.7 and
Figure 6, poverty varies substantially between countries from one percent to 60 percent.
The concept of the poverty can be misleading though. According to the CIA World
Factbook, the “definitions o f poverty vary considerably among nations” and “rich nations
generally employ more generous standards o f poverty than poor nations” (www.cia.gov
2004). This makes it much more difficult to determine an association between poverty
and rheumatoid arthritis. Table 3.6 and Figure 10 in Chapter III show that in this study
poverty is not a good indicator o f the prevalence o f rheumatoid arthritis in a population.
Yet poverty should contribute to the health o f nations. Being below the poverty line
indicates that the income level is insufficient to sustain a family in terms of food,
housing, clothing, medical needs, and various other factors.

Accessibility of Health Care
Accessibility o f health care, “a measure o f the proportion of a population that
reaches appropriate health services” (www.euro.who.int 2004), has significance when
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accounting for differences in prevalence o f rheumatoid arthritis between countries. Many
people in developed and developing countries cannot afford to seek such services or none
are provided for them. In most developing countries, medical services are often
unavailable, inaccessible or unaffordable. Although, it is worth mentioning that “there
are great disparities in wealth and levels of health care achieved in developing countries,
thus it is difficult to generalize from one geographical area to another” (Ojanuga and
Gilbert 1992:615). This is an important factor when considering treatment and
preventative measures for rheumatoid arthritis, and many other diseases as well, for all
parts of the world.
Accessibility is a measure of geographical, financial and cultural factors.
Geographical accessibility is a measure o f the degree to which services are available and
accessible to a population (www.euro.who.int 2004). In many developed countries, many
people are within close proximity to a clinic or hospital. Even in rural areas, it is more
likely that a clinic will be only a short drive away. Transportation is also readily
available, as almost everyone has access to a vehicle and many towns and cities have
inexpensive public transportation (bus, subway). But in many developing countries
health care facilities are much less accessible because of distance, lack of transportation
or simply the absence of adequate health care facilities. Geographical accessibility may
also work in the opposite regard as well. Some individuals may not be able to be
contacted by research teams because of the remoteness o f where they live. For
researchers conducting population surveys on a random sample of individuals, some will
be neglected due to the time and effort required to access their location.
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Financial accessibility is a measure of the degree a population is able to pay for
health care (www.euro.who.int 2004). For instance, even if health care facilities exist
and are geographically accessible, many people cannot afford such services and/or do not
have health care coverage. Many conditions require expensive medications, frequent
physician visits and even hospitalization. For a chronic disease like rheumatoid arthritis,
this expense will continue for the duration o f the patient’s life. Without adequate health
insurance or wealth, many may not receive the proper treatment for the disease causing a
worse outcome with increased disability. This applies to people all over the world, in
developed and developing countries.
Cultural accessibility is a measure of the degree for which cultural taboos limit
access to health care (www.euro.who.int 2004) and is important in determining possible
risk factors and potential consequences o f rheumatoid arthritis for the individual. In
many countries, culture plays a large role in the manner in which people carry out their
lives. For instance, ones culture may determine whether a woman may receive medical
attention from a male doctor or even be permitted to seek such services without the
consent of her husband (Ojanuga and Gilbert 1992). According to Ojanuga and Gilbert,
women in developing countries “tend to utilize health facilities less than men even
though their need for health care is greater” (Ojanuga and Gilbert 1992:614). For women
with rheumatoid arthritis this may have a profound affect on their physical ability to
maintain the same level of daily activity they had before the disease initiated. Some
minority groups may not feel comfortable attending a health care facility that is mainly
staffed by those o f a different ethnicity or o f the majority population. This may be due to
feelings of discrimination or because o f the absence of common values. Also some
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individuals of certain cultures may not seek medical attention for processes that are
considered natural, such as childbirth and osteoarthritis (www.euro.who.int 2004).
Regardless o f the specific cultural reason for restricting access to medical care, the health
o f many individuals can be affected by their cultural identity.
Accessibility of Health Care in the United States
Although many feel that poor accessibility to health care only affects individuals
in developing countries, it is also a problem in the United States, a developed country.
Larger countries have the added complication of having to deal with multiple
subpopulations with differing beliefs and expectations. The increase in immigrant
populations in the United States has recently focused the attention of many towards racial
and ethnic health disparities that negatively influence access to health care. This involves
multiple causes, such as health care systems, providers, and patients, but some play a
larger role than others.
For example, physicians may discriminate against their patients. This can occur
consciously or subconsciously based on biases or stereotypes previously formed about
populations different from their own. A survey conducted by The Henry J. Kaiser Family
Foundation in 1999 found that African Americans were “fourteen times as likely to report
that they were treated unfairly because of race when seeking medical care” (Smedley et
al. 2003:636). Many other studies have been conducted that support physician bias, with
their subject matter pertaining to patient and physician assessment of care, surveys
blinded to patient race and ethnicity, and physician responses to white and black patients
with identical symptoms. A study, conducted by Shi, claims that even when controlling
for sociodemographic and health-status differences, many racial and ethnic minorities
57

experienced “worse first-contact primary care than whites” in the United States (Shi
1999:1073). Yet not all studies have shown racial and ethnic minorities to be at a
disadvantage. Two studies comparing white, African American and/or Hispanic patients
with rheumatoid arthritis reported no differences in pain, disability and overall physical
function (Jordan 1999).
This disparity goes beyond race or ethnicity and may also lie in socioeconomic
status as well. A study conducted in urban California, published in 1995, reports that
people living in low-income areas were more likely to be hospitalized for chronic
conditions than people living in high-income areas (Bindman et al. 1995). This seems to
correlate with their perception about the accessibility of health care as well. Individuals
who feel they have poor accessibility to health care are often those who are hospitalized
for conditions that could have otherwise been avoided if they had initially sought proper
treatment.
Another factor that may contribute to racial and ethnic disparities in health care in
the United States is the lack o f availability of affordable public or private health
insurance. This has continued to be a problem regardless of the establishment of
programs such as Medicare and Medicaid. For many this may be due to the overall
expense, but for immigrant populations, fear of divulging too much information about
oneself or family, or fear o f jeopardizing their application for citizenship may also play a
role. Unfortunately most of these fears are “based on a misunderstanding of federal
policies” (Smedley et al. 2003:648). Several statistics from the National Center for
Health Statistics demonstrate this disparity. For example in 2004, 26.3 percent of
Hispanics at the time o f the interview had been uninsured for more than a year versus
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only 6.1 percent o f whites at the time o f the interview. Many o f those who are
unemployed or are below the poverty line also find themselves uninsured. In 2004, it
was reported that almost 58 percent o f currently unemployed adults had been uninsured
for part of the year and about one third o f currently unemployed adults had been
uninsured for more than a year (www.cdc.gov 2004). Unfortunately, insuring the
previously uninsured may not overcome the disparity that many minority groups may
experience when seeking medical attention in the United States.
The potential for racial and ethnic discrimination still exists and may play a large
role in explaining the persistence of disparities in health care in the United States. Efforts
must be made in the United States and in all countries “to provide ethnically and
culturally competent care and to remove or reduce the many barriers facing racial/ethnic
minorities in their access to primary care” (Shi 1999:1074). This differential treatment of
minority populations is not unique to the United States. It has been demonstrated that
Aboriginal people in Australia, Inuit people in Canada, African immigrants in France,
Russian immigrants in Israel, and the non-white majority population in South Africa also
face unequal accessibility and content o f health care (Smedley et al. 2003).
Other Explanations
Although accessibility o f health care may contribute to the uneven reported
prevalence data between North American and non-North American populations, it will
not determine the prevalence o f rheumatoid arthritis. Other factors that may also affect
the prevalence data must also be considered, such as cultural values, communication and
language barriers, and expectations and attitudes towards modem medicine.
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Cultural values and local cultural differences are important considerations when
comparing the prevalence o f rheumatoid arthritis for all populations. Culture is ingrained
into many daily activities for people in developed and developing countries and may
affect every aspect of their lives. This may limit many people’s willingness to discuss or
disclose certain health conditions to a stranger conducting a survey in their area. Many
cultures may consider this to be private information that should not be revealed to anyone
and may even be kept hidden from family and friends. This is the opposite of many non
immigrant populations living in the United States who lack any relevant cultural
restrictions. Some individuals may even have a much greater propensity to report and
discuss their health issues with anyone and even manifest some for attention.
Often there are problems with communication with the people involved in the
study because of a language barrier. Without an interpreter to assist with the interview or
having previously translated the questionnaire, many of those surveyed may misinterpret
the questions. This could lead to highly inaccurate results. For example, with languages
other than English, problems may occur when trying to differentiate or distinguish levels
of pain and disability, as there may not be similar words to describe it. A study
conducted in Britain and France reported, “qualitative sociological and anthropological
evidence supports the hypothesis o f a socially differentiated interpretation o f illness”
(Aiach and Curtis 1990:271) and it is likely to be even more apparent between developed
and developing countries. Those conducting population studies must consider and
investigate this issue prior to working in an environment unlike their own. This is
important since many researchers may not be from the country or culture they are
studying and cannot fully relate to their patients. Time and monetary constraints may
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also affect researchers’ ability to fully investigate and assess patient’s symptoms in
situations where language barriers exist. These problems with communication
undoubtedly exist with many individuals who seek general medical services as well.
Also attitudes towards and expectations from modem medicine differ between
cultures. Some individuals may not seek medical attention from a physician but may
look toward a traditional or local healer for medical advice and treatment. Some may
feel commercial medicines are not safe and instead treat themselves with herbal
supplements which they do not acknowledge as medicine. Others may not reveal that
they are taking anything at all for their symptoms. Regardless, not reporting the ingestion
of any medicine or consultation with a traditional healer may alter the results of the study
due to negative clinical findings o f rheumatoid arthritis during the initial interview.
Minority patients have also been shown to be “more likely to refuse recommended
services, adhere poorly to treatment regimens, and delay seeking care ”(Smedley et al.
2003:7). This behavior can be brought on in individuals by a variety of factors mostly
due to a mismatch between patient and provider. This affects citizens of the United
States as well as all other countries with diverse populations, although it does not fully
explain the healthcare disparities faced by many racial and ethnic minorities.
Antiquity and Etiology
Two other factors that may contribute to the difference in prevalence rate of
rheumatoid arthritis for North American and non-North American populations include
antiquity and etiology. Both were discussed at length in Chapter II. Unfortunately
neither is completely understood and both require further investigation and research.
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This makes their role in the present study inconclusive but they undoubtedly play a large
role in the expression o f rheumatoid arthritis.
The prevalence of rheumatoid arthritis in North American ancestral groups is
higher than in any other non-North American ancestral group as shown in Chapter II,
Figures 1 and 2. The prevalence is especially high with the Native American population
{Mongoloid North American subgroup). As mentioned in Chapter I, the antiquity of
rheumatoid arthritis has yet to be proven, but it may have originated in the Tennessee
River Valley o f the United States as early as 6500 BC with the Native American
population. The correlation between possible place of origin and high prevalence rate
should not be overlooked here or in other studies like the present one. Could there be one
or a combination o f environmental factors that North Americans are exposed to that are
absent or very minimal elsewhere? Isolating an environmental stimulant seems almost
impossible at this time, as there are many factors to be considered. The lack of
knowledge about the etiology o f rheumatoid arthritis only makes this question more
complicated. Regardless, the proposed geographic area and population of origination of
rheumatoid arthritis should be given consideration as a potential factor explaining the
increased prevalence o f rheumatoid arthritis in North American populations.
The etiology o f rheumatoid arthritis should also be considered as playing a role in
the difference in prevalence between North American and non-North American
populations. The genetic, environmental, hormonal, and immunologic factors of the
etiology o f rheumatoid arthritis are described in detail in Chapter II. There are many
factors that could potentially be contributing to the expression of this disease, so many
that determining which one(s) result in the expression o f rheumatoid arthritis has thus far
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proven to be an impossible task. The problem is there are so many inconsistencies
between individuals afflicted with the disease. What appears to cause rheumatoid
arthritis in some people is completely absent in others. Its onset can occur in the teens up
through the elder years, several levels o f severity exist with some individuals having a
complete remission of symptoms, and some scientists state that rheumatoid arthritis is not
actually an autoimmune disease. The unpredictability and irregularity of rheumatoid
arthritis has left many physicians and their patients understandably unsettled.
Nonetheless, the etiology o f rheumatoid arthritis should be considered a potential factor
affecting the inconsistency in prevalence between North American and non-North
American populations.
Conclusion
The discussion o f several explanations regarding the difference in prevalence of
rheumatoid arthritis between North American and non-North American ancestral groups
has just been presented. This included economic and demographic variables as well as
accessibility to health care, cultural values, communication, expectations, and the
antiquity and etiology o f rheumatoid arthritis. Any one or a combination of several of
these factors could play a significant role in the outcome and expression of rheumatoid
arthritis, but how they contribute to the prevalence rate for each of the studies included
here is the real question that needs to be answered.
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CHAPTER V
CONCLUSIONS
The current chapter seeks to clarify the impact each of the variables discussed in
Chapter IV (economic and demographic variables, accessibility of health care, cultural
values, problems with communication, expectations and attitudes towards modem
medicine and health care, and antiquity and etiology of rheumatoid arthritis) has on the
results and conclusion o f all of the prevalence studies included in this study.
Summary
Hypothesis 1: The prevalence of rheumatoid arthritis will be lower among the
ancestral groups o f North American when compared to ancestral groups living on other
continents due to the advanced health care available in North America, and more
specifically the United States.
Hypothesis 1 was proven false. Considering that the United States is a developed
country with some of the most advanced medical care, it was rather unexpected that all
three ancestral groups (Caucasoid, Mongoloid, Negroid) in North America had a
noticeably higher prevalence of rheumatoid arthritis than all ancestral groups living
elsewhere. The prevalence o f rheumatoid arthritis in the Mongoloid group of the North
American subgroup seems appropriately increased when considering some believe
rheumatoid arthritis may have originally began with the Native American population,
which makes up the entire subgroup for North America.
Hypothesis 2: The prevalence o f rheumatoid arthritis can be partially explained
by carefully selected economic and demographic variables for each country addressed in
this study.
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Hypothesis 2 was proven false. None of the four variables (gross domestic
product-per capita, life expectancy o f the total population, percentage of the population
65 years and older, and percentage of the population below the poverty line) were found
to have influence over or be a good predictor of the prevalence of rheumatoid arthritis for
any o f the studies included. Substantial variability in the prevalence of rheumatoid
arthritis was found between poor and wealthy countries as well as countries with a large
young or elderly population.
Hypothesis 3: Studies conducted on the prevalence of rheumatoid arthritis will be
influenced by factors that are often not given adequate consideration.
Hypothesis 3 was found to be true. The variability in prevalence of rheumatoid
arthritis among the studies was found to be influenced more heavily by communication
problems and cultural values than by the disease itself or by the four variables discussed
in Hypothesis 2.
Conclusions
The gross domestic product- per capita, life expectancy of the total population,
percentage o f the population 65 years and older, and the percentage of the population
below the poverty line did not appear to play any role in explaining the uneven
prevalence of rheumatoid arthritis between North American and non-North American
subgroups. Countries that are economically stable and have a significant elderly
population can have either a high or low prevalence of rheumatoid arthritis. This also
applies to poor nations whose populations rarely live to reach 70 years old. An example
that does not fit preconceived ideas about the health of individuals in particular countries
is China, which has a life expectancy of about 72 years, a gross domestic product-per
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capita of 5,000 dollars, but a prevalence o f rheumatoid arthritis of 0.37 percent. Another
example is the country of Lesotho, which has a gross domestic product-per capita of
3,000 dollars, a prevalence o f rheumatoid arthritis of 1.8 percent but a life expectancy of
only about 37 years. Clearly for the prevalence studies included in this study, a
connection cannot be made between rheumatoid arthritis prevalence and economic
standing for any country. Yet the four variables do show consistency and exhibit
regularity among the countries included here. Typically, a country that has a high gross
domestic product-per capita and a low percentage of the population below the poverty
line will also have a high life expectancy and a high percentage of the population 65
years and older. Unfortunately these four variables do not help to explain the difference
in prevalence of rheumatoid arthritis between North American and non-North American
populations, but they do provide information about the general health care that should be
available to individuals living in each country.
The accessibility of health care was discussed at length in Chapter IV. Regardless
of the economic standing o f each country included in this study, individuals in the United
States and other countries, both developed and developing, face problems with
geographical, financial and cultural barriers when seeking medical attention for minor
and major health problems. For poor nations with large rural populations, this is not
surprising. But the health care in the United States, believed to be one o f the best, has
been shown to be unavailable and inadequate for many individuals. Mostly immigrant
and minority populations as well as individuals with a low socioeconomic status are
affected, according to some rather unexpected statistics and studies conducted in the past
few years. Considering that poor accessibility of health care affects nearly every
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population and country, it is difficult to associate it with any difference in prevalence rate
o f rheumatoid arthritis found when comparing countries/populations. Therefore it
appears to have no impact on the outcome of any o f the studies included here or on the
present study.
Cultural values exist in many different forms among many different populations.
To make the statement that they may affect an individuals* willingness to disclose
personal information to a stranger may be too much of a generalization. But for the
present argument, it is appropriate. The bulk of the North American data comes fi*om a
study conducted in the early 1960s, and several studies on Native American populations
exclusively over several decades. The 1960s study, which covers all three ancestral
groups, is assumed to not have included a large immigrant population and was
predominantly second or third generation Americans. Immigrant populations were
probably not neglected, but the response rate from them was almost certainly rather low.
The Native American population studies {Mongoloid North American subgroup) included
here were conducted from the 1960s through the 1990s. These populations have not been
living in isolation and have been undoubtedly influenced by American culture. As
discussed in Chapter IV, the non immigrant population living in the United States has a
much greater propensity to divulge personal information, in general, than populations
living in other developed and developing countries. Therefore, it seems that cultural
values can undeniably alter the outcome o f population studies conducted in areas where
they are prevalent and look to be a significant factor to explain the uneven distribution of
rheumatoid arthritis worldwide.
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Excellent communication between researcher and participants is essential for
accurate results when conducting studies on populations using a different language. An
inability to fully comprehend questions and responses may lead to erroneous conclusions
based on avoidable misunderstandings. Eliminating the communication or language
barrier is solely the responsible of those conducting the population study and should be
dealt with long before the study is underway. The issue of communication is not
addressed in most of the prevalence studies included here or is at least not disclosed in
the published article. Information on the background of the authors involved in the study
and any translations taken place with the questionnaire would be helpful to resolve this
matter. If even half of the researchers had problems communicating with the participants
included in the studies or if the participants had trouble understanding the questionnaire,
the potential for inaccurate results exists. When working with prevalence rates that only
differ by tenths of a percent, accuracy is crucial. For that reason, the language barrier
that may have been present between researcher and participant may have significantly
affected the conclusion formed in each o f the prevalence studies included, thereby
affecting the outcome o f this study as well.
The thought o f seeking medical attention from modem medical services conjures
up many different ideas and feelings from individuals in both developed and developing
countries. These attitudes and expectations often result from cultural values or from
experiences in the past. Some individuals may choose to seek other alternatives to
modem medicine when in need o f medical attention including traditional healers or
herbal supplements. These individuals would be missed if the prevalence studies used
medical records from hospitals and clinics to find those afflicted with rheumatoid
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arthritis. But, as part of the criteria created for the present study, all prevalence studies
included here must have interviewed a representative or random sample of the population
to ensure that all o f the defined survey areas were properly sampled. Unless the
interview refusal rate for those opposed to modem medicine was high, which is
undeterminable, the expectations and attitudes individuals have towards modem medicine
should not have affected the outcome of the prevalence studies included and therefore
should not affect the conclusion o f the present study either.
The antiquity o f rheumatoid arthritis is not fully understood, but an increasing
number of skeletal remains continue to be found during archaeological excavations.
Through analysis, skeletal remains will help to provide further proof of either a European
or North American origin. If rheumatoid arthritis did first develop in North America, it
may explain why the prevalence rate is considerably higher in Native Americans than in
any other population around the world. It may also explain why the prevalence rate of
rheumatoid arthritis is higher in all three subgroups of North American than those in nonNorth American subgroups. But since the origin is not known, it is impossible to connect
the antiquity of rheumatoid arthritis with the higher prevalence in North America. As a
result, it cannot be presumed to have affected the results of any of the prevalence studies
included here.
The etiology of rheumatoid arthritis is essentially unknown as well. Scientists
have been researching potential causes for decades but have not found one or a multiple
of factors that are consistently found in every individual with rheumatoid arthritis. This
has left many individuals afflicted with rheumatoid arthritis and the physicians treating
them unsettled. Fortunately many new medications, though very expensive, have been
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developed to stop the progress of joint damage rather effectively. Nonetheless, until the
etiology of rheumatoid arthritis is uncovered and a cure is eventually found, the etiology
cannot be implicated as a potential cause/factor to explain the difference in prevalence of
rheumatoid arthritis between North American and non-North American subgroups.
Although all of the potential causal factors discussed in Chapter IV are important
to consider when comparing multiple studies conducted on several populations by
different investigators, many o f them, as discussed, do not play any significant role in the
conclusion of the present study. This is not to say that they do not influence the health of
the populations being studied, but that they do not contribute to the outcome of this
comparison. O f the seven variables discussed only two, cultural values and
communication, were found to have considerable affect on the results of the prevalence
studies included here.
Concluding Remarks
It is probable that in the future we will see chronic diseases, such as rheumatoid
arthritis, become major health concerns, as many of these diseases tend to increase with
age. Altering this predicted rise in the number o f individuals developing rheumatoid
arthritis is necessary to ease the global suffering many could potentially face. A broad
knowledge and understanding o f rheumatoid arthritis and its prevalence provides the
foundation to promote education, research and ultimately prevention. Hopefully the
present study and all subsequent studies like it will bring us one step closer to a complete
understanding of this complex disease and to reducing the disability so many are already
facing.
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